Point of Care Diagnostics For Maternal Health Market Research Report Segmented By Type of Tests (Pregnancy Tests, Infectious Disease Testing, Foetal Health Testing, Labour Delivery, Monitoring, and Others); By End-User (Hospitals & Clinics, At-Home Care, Diagnostic Laboratories & Centers, and Others); and Region- Size, Share, Growth Analysis | Forecast (2024 2030)

Point of Care Diagnostics for Maternal Health Market Size (2024 – 2030)

The market for Point of Care Diagnostics for Maternal Health attained a valuation of USD 38.70 million in 2023 and is expected to achieve USD 65.55 million by the conclusion of 2030. Throughout the projected period from 2024 to 2030, the market is forecasted to exhibit a Compound Annual Growth Rate (CAGR) of 7.82%.

Historically, diagnostic capabilities for maternal health were restricted due to the absence of robust healthcare infrastructure and technological advancements. This led to elevated maternal mortality rates, subsequently resulting in complications during future pregnancies. Moreover, entrenched cultural and societal norms favored traditional home remedies over diagnostic practices, adversely affecting the long-term well-being of women. However, contemporary circumstances have witnessed a significant transformation in maternal healthcare, driven by technological advancements such as genetic testing, ultrasound integration, rapid blood and urine testing devices, and the expansion of digital healthcare solutions. These innovations have substantially diminished mortality rates and contributed to the advancement of maternal healthcare. The future outlook is optimistic for the Point of Care Diagnostics for Maternal Health Market, with anticipated growth trends in Artificial Intelligence (AI), machine learning, big data, and other technological advancements poised to enhance diagnostic opportunities. Additionally, increased healthcare awareness, coupled with government support for health technology, is shaping the landscape of point-of-care diagnostics for maternal health.

Key Market Insights:

According to the World Health Organization (WHO), 95% of maternal deaths occurred in low and lower-middle-income countries in 2020. The birth rate in India recorded 17.377 births per 1000 people in 2021. Notably, at-home pregnancy tests, as per the Cleveland Clinic, boast a 99% accuracy rate when used correctly. UNICEF reports that approximately 73% of births among rural mothers were assisted by skilled health personnel. Institutional deliveries in India surged to 89% in 2019-20 compared to previous periods. A global health survey conducted by BMJ Global Health found that 58% of maternal and infant health providers utilized telehealth.

Point of Care Diagnostics for Maternal Health Market Drivers:

Elevated risks in maternal health have fueled the demand for point-of-care diagnostics in the market.

Maternal health faces diverse risks, with casualties escalating rapidly in recent years. WHO data from 2020 revealed that 800 women succumbed daily to preventable causes related to pregnancy and childbirth. Factors contributing to these risks range from environmental impacts on both mother and baby to genetic complications requiring thorough analysis. This has led to an increased demand for point-of-care diagnostics for maternal health in the market. Moreover, many pregnant women grapple with chronic diseases like heart disease, hypertension, anxiety disorders, obesity, thyroid conditions, diabetes, and more, directly impacting the baby. The incorporation of point-of-care diagnostics aids in mitigating these risks, offering monitoring and early detection capabilities for abnormalities in pregnancy, such as genetic diseases' impact on the baby, potential infections, post-natal issues, chromosomal abnormalities, and others.

Growing demand for convenient diagnosis propels the market growth of point-of-care diagnostics for maternal health.

The surge in demand for convenient diagnostics is attributed to the hectic lifestyles and increased workforce participation of women. These diagnostics provide rapid, efficient, and accurate results at home, reducing casualties and delays in regions with inadequate healthcare infrastructure. Furthermore, they offer a hassle-free alternative for women, eliminating the need for doctor appointments for testing and diagnosis, significantly reducing waiting times. The integration of smart technologies into mobile devices and tablets, including AI support, has further shaped the market landscape for point-of-care diagnostics for maternal health. Additionally, it provides personalized and tailored solutions to women, addressing various testing and monitoring needs on a single platform. The rising demand for automated and portable technologies, such as portable ultrasound devices and pregnancy monitoring devices, has further stimulated the demand for convenient at-home maternal health care solutions in the market.

Point of Care Diagnostics for Maternal Health Market Restraints and Challenges:

Quality and accuracy concerns pose potential hindrances to the market growth of point-of-care diagnostics for maternal health. Some Point of Care Diagnostics (POCD) testing kits may yield inaccurate results, impacting the treatment process for maternal health.

Furthermore, the complexity associated with handling at-home care testing kits may diminish consumer demand for point-of-care diagnostics for maternal health in the market.

Point of Care Diagnostics for Maternal Health Market Opportunities:

The Point of Care Diagnostics for Maternal Health Market is poised to offer lucrative opportunities for businesses, including acquisitions, partnerships, collaborations, product launches, and agreements during the forecasted period. Moreover, the increasing demand for convenient diagnostic technologies and the rapid adoption of telehealth in various countries are expected to foster the development of the Point of Care Diagnostics for Maternal Health market and enhance its future growth prospects.

Point of Care Diagnostics For Maternal Health Market Segmentation: By Type of Tests

• Pregnancy Tests
• Infectious Disease Testing
• Foetal Health Testing
• Labour Delivery Monitoring
• Others

In the year 2022, concerning the categorization of tests, pregnancy tests dominate the market share, constituting approximately 29%. This dominance is primarily attributed to the widespread use of pregnancy kits within this category, encompassing at-home pregnancy test kits, urine hCG test kits, blood serum hCG test kits, and others. These kits play a pivotal role in monitoring and confirming pregnancies, detecting early stages, and facilitating immediate treatment. Consequently, they have significantly reduced delays and complications associated with pregnancy, ensuring healthcare professionals provide timely and appropriate interventions.

The segment experiencing the swiftest growth during the forecast period is foetal health testing. This testing category assumes critical importance in maternal health by focusing on assessing the fetus's developmental status and identifying potential complications. Technologies such as ultrasound scanners, fetal heart rate monitoring devices, and non-evasive prenatal testing contribute to this growth, aiding in the early detection of diseases and genetic abnormalities. The integration of these tests has not only diminished prenatal mortality but has also enhanced the overall efficiency of maternal treatment.

Point of Care Diagnostics For Maternal Health Market Segmentation: By End-User

• Hospitals & Clinics
• At-Home Care
• Diagnostic Laboratories & Centers
• Others

As of 2022, based on end-users, hospitals & clinics command the largest share at approximately 34% in the market. This is attributed to their role as major consumers of point-of-care testing for maternal health, catering to a substantial number of pregnant women. The testing kits and devices utilized in hospitals and clinics aid in the analysis, monitoring, and detection of anomalies in pregnant women and their babies, facilitating the delivery of appropriate and timely treatment.

The at-home care segment is the fastest-growing category during the forecast period. The surge in demand for quick and accurate results, coupled with a shortage of professional health services in certain regions, propels the growth of this segment. Notably, pregnancy kits constitute a significant share in this segment, empowering women to perform pregnancy tests conveniently at home and detect early-stage pregnancies. Additionally, these kits facilitate the self-monitoring of health parameters such as blood pressure and glucose levels during pregnancy.

Point of Care Diagnostics For Maternal Health Market Segmentation: Regional Analysis

• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

In 2022, regional segmentation reveals that North America holds the largest market share, accounting for approximately 26.5%. This growth is attributed to well-established maternal healthcare services and technologically advanced kits, contributing to quicker, more efficient, and accurate results in the region.

The Asia-Pacific region emerges as the fastest-growing market during the forecast period, fueled by increasing birth rates in countries like India and China. The rapid adoption of telehealth and medicine, along with governmental support through schemes and programs for women and children, further amplifies the demand for point-of-care diagnostics for maternal health in this region.

COVID-19 Impact Analysis on the Point of Care Diagnostics For Maternal Health Market

The pandemic has had a positive impact on the point-of-care diagnostics for maternal health market. The shortage of healthcare services during the pandemic led to an increased demand for at-home testing kits through e-commerce platforms. The trend towards digitization, coupled with the surge in telehealth and telemedicine, helped mitigate treatment delays. Real-time monitoring kits for pregnancy, fetus, and maternal health allowed women to send data directly to healthcare professionals for analysis. Integrated into mobile applications, these kits enabled remote monitoring and analysis of maternal health, facilitating timely recommendations and treatment.

Latest Developments:

The point-of-care diagnostics for maternal health market is witnessing an upward trend due to new product launches and technological innovations. The integration of AI, ML, and big data technologies with testing kits has transformed the diagnostic procedure, making it easier for healthcare professionals to deploy appropriate treatment procedures. The increased online presence of medical and healthcare companies is expected to further boost the market.

In September 2024, Yourgene Health introduced MagBench, an automated DNA extraction instrument and kit designed for collecting samples for prenatal testing. This product, available in the Asia-Pacific and Middle East markets, extracts DNA from maternal plasma, enabling clinical laboratories to offer accurate solutions for non-invasive prenatal testing services.

In June 2024, Salignostics, a UK-based testing kit company, launched Salistick, a saliva-based pregnancy testing kit. Aimed at determining pregnancy through a spit test, the product provides an alternative to urine-based pregnancy tests and is available in the UK and Ireland.

Key Players:

1. Maternova
2. DiaSYs
3. EKF Diagnostics
4. AdvinHealthcare
5. AccuQuik Test Kits
6. Ancestry
7. My Heritage
8. Nebula Genomics
9. Sera Prognostics
10. Labcorp Women’s Health